# SciAnda (Changshu) Pharmaceuticals, Ltd. – FDA Inspection, Mar 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/scianda-changshu-pharmaceuticals-ltd/0b6ff7e0-40fb-4095-befd-9a8458d48fc8
Source feed: FDA_Inspections

> FDA inspection 1237197 of SciAnda (Changshu) Pharmaceuticals, Ltd., March 29, 2024. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237197
- Company Name: SciAnda (Changshu) Pharmaceuticals, Ltd.
- Inspection Date: 2024-03-29
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 951273 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/scianda-changshu-pharmaceuticals-ltd/0caa5491-2369-4132-b3de-0e6d1ae1d81e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.keypedia.com/companies/scianda-changshu-pharmaceuticals-ltd/a06add48-1cb1-4865-9266-1f99991e904c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c